Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
Upturn AI SWOT - About
iShares Trust - iShares Neuroscience and Healthcare ETF (IBRN)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
08/14/2025: IBRN (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Analysis of Past Performance
Type ETF | Historic Profit 9.59% | Avg. Invested days 49 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Star Rating | Upturn Advisory Performance  3.0 | ETF Returns Performance  3.0 |
| Profits based on simulation | Last Close 08/14/2025 |
Key Highlights
Volume (30-day avg) - | Beta - | 52 Weeks Range 17.86 - 28.63 | Updated Date 06/29/2025 |
52 Weeks Range 17.86 - 28.63 | Updated Date 06/29/2025 |
Upturn AI SWOT
iShares Trust - iShares Neuroscience and Healthcare ETF
ETF Overview
Overview
The iShares Neuroscience and Healthcare ETF (IBrain) aims to provide exposure to companies that could benefit from advances in neuroscience and healthcare innovation. It focuses on companies involved in the research, development, and production of therapies, diagnostics, and technologies related to brain health and neurological disorders.
Reputation and Reliability
iShares, a brand of BlackRock, is a leading issuer of ETFs with a strong reputation for providing diverse and well-managed investment products.
Management Expertise
BlackRock has extensive experience and expertise in managing ETFs, including thematic and sector-specific funds.
Investment Objective
Goal
The primary investment objective of iBrain is to track the investment results of an index composed of developed and emerging market companies that could benefit from advances in neuroscience and healthcare innovation.
Investment Approach and Strategy
Strategy: iBrain employs a passively managed approach, aiming to replicate the performance of its underlying index, the NYSE FactSet Global Brain Health Index.
Composition The ETF's assets primarily consist of stocks of companies involved in neuroscience, biotechnology, pharmaceuticals, medical devices, and related industries.
Market Position
Market Share: Insufficient data available to calculate an exact market share for this specific niche ETF.
Total Net Assets (AUM): 35630000
Competitors
Key Competitors
- ARK Genomic Revolution ETF (ARKG)
- SPDR S&P Biotech ETF (XBI)
- VanEck Biotech ETF (BBH)
Competitive Landscape
The competitive landscape includes broader biotech and genomics ETFs, as well as other specialized healthcare funds. iBrain distinguishes itself with its specific focus on neuroscience and brain health, offering investors targeted exposure. However, its smaller size might lead to lower liquidity compared to more established funds.
Financial Performance
Historical Performance: Historical performance data requires specific date ranges and can be obtained from financial data providers. (e.g., Bloomberg, Yahoo Finance)
Benchmark Comparison: Benchmark comparison data requires specific date ranges and can be obtained from financial data providers. (e.g., Bloomberg, Yahoo Finance)
Expense Ratio: 0.47
Liquidity
Average Trading Volume
The average trading volume of iBrain can vary but is generally lower than broader market ETFs, reflecting its niche focus.
Bid-Ask Spread
The bid-ask spread for iBrain can be wider than more liquid ETFs, potentially increasing the cost of trading.
Market Dynamics
Market Environment Factors
Advances in neuroscience, increasing prevalence of neurological disorders, and growing investment in biotechnology are key factors influencing iBrain.
Growth Trajectory
The growth trajectory depends on the pace of innovation in neuroscience and healthcare, as well as investor interest in thematic ETFs.
Moat and Competitive Advantages
Competitive Edge
iBrain offers a unique focus on neuroscience and brain health, differentiating it from broader healthcare or biotech ETFs. This targeted approach allows investors to gain specific exposure to companies involved in cutting-edge research and treatment for neurological disorders. The ETF's underlying index provides a specialized and concentrated portfolio. However, this niche focus also makes it riskier than more diversified healthcare funds.
Risk Analysis
Volatility
iBrain's volatility is likely to be higher than broader market ETFs due to its concentration in a specific sector.
Market Risk
Market risk includes regulatory changes, clinical trial failures, and shifts in investor sentiment towards biotechnology and pharmaceutical companies.
Investor Profile
Ideal Investor Profile
The ideal investor is someone interested in the long-term growth potential of neuroscience and healthcare innovation and comfortable with the higher risk associated with a niche sector ETF.
Market Risk
iBrain is more suitable for long-term investors with a high-risk tolerance than for active traders seeking short-term gains.
Summary
The iShares Neuroscience and Healthcare ETF (IBrain) provides targeted exposure to companies benefiting from advances in neuroscience and brain health. Its niche focus offers unique investment opportunities but also higher risk. It's suitable for long-term investors with a high-risk tolerance interested in this specific sector. The ETF's performance is dependent on the success of companies within the neuroscience and healthcare fields, with regulatory changes and clinical trial results posing a potential risk. Investors should carefully consider its niche focus and higher volatility compared to broader market ETFs.
Peer Comparison
Sources and Disclaimers
Data Sources:
- iShares website
- Bloomberg
- SEC Filings
- ETF.com
- Yahoo Finance
Disclaimers:
The data provided is for informational purposes only and should not be considered investment advice. Investment decisions should be based on individual circumstances and consultation with a qualified financial advisor. Past performance is not indicative of future results.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About iShares Trust - iShares Neuroscience and Healthcare ETF
Exchange NYSE ARCA | Headquaters - | ||
IPO Launch date - | CEO - | ||
Sector - | Industry - | Full time employees - | Website |
Full time employees - | Website | ||
The fund will invest at least 80% of its assets in the component securities of its index and in investments that have economic characteristics that are substantially identical to the component securities of its index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents as well as in securities not included in the index, but which BFA believes will help the fund track the index. It is non-diversified.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.